Evidence mapPaperPMID 41322301Full record

ArticleFrontiers in pharmacology2025

Vincent Rönnpagel, Felix Morof, Giuliano Ciarimboli, Markus Grube, Marleen J Meyer-Tönnies, Mladen V Tzvetkov

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vincent RönnpagelDepartment of General Pharmacology, Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Greifswald, Germany.
Felix MorofDepartment of General Pharmacology, Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Greifswald, Germany.
Giuliano CiarimboliExperimental Nephrology, Medicine Clinic D, Münster University Hospital, Münster, Germany.
Markus GrubeDepartment of General Pharmacology, Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Greifswald, Germany.
Marleen J Meyer-TönniesDepartment of General Pharmacology, Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Greifswald, Germany.
Mladen V TzvetkovDepartment of General Pharmacology, Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Greifswald, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The liver plays a critical role in drug pharmacokinetics. In Methods: After euthanizing, the liver of 6- to 28-week-old mice was perfused via an indwelling venous catheter in the portal vein as entry and into the caudal vena cava toward the heart as exit. Perfusion solutions were prewarmed to 42 °C and pumped at 2 mL/min. First, HBSS supplemented with 0.5 mM EDTA was used to exsanguinate the liver, followed by HBSS alone and then HBSS containing the drug of interest. Drug and metabolite concentrations in the perfusates were measured by LC-MS/MS. Results and conclusion: The method enables reproducible and reliable perfusion of mouse livers. We applied it to study the effects of Oct1 knockout on drug metabolism. Oct1 knockout affected the first-pass metabolism of codeine, including the formation of the metabolites morphine and morphine-3-glucuronide, as well as the first-pass metabolism of proguanil and the formation of cycloguanil. The model is applicable to any mouse strain, genetic background, and substrate of interest and is thus applicable to a wide variety of research questions.

Indexed as

codeinedrug transporterfirst-pass simulationmorphinemouse liver perfusionOCT1pharmacokineticsproguanil

Identifiers

PMID41322301
PMCPMC12660287

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.